By Nathan Gomes (Reuters) - Harley-Davidson (NYSE:HOG) on Thursday warned of a hit to its full-year results from tariffs and suspended its 2025 forecasts as the motorcycle maker expects a bumpy ride due to U.S. President Donald Trump’s trade policies. The company, which had previously projected a flat to 5% decline in annual per-share profit, took a $9 million hit in the first quarter and said i ...
Investing.com -- RBC Capital Markets has downgraded Schindler Holding AG (SIX:SCHN)G to “sector perform,” citing a steep run-up in the stock that has left little room for further upside, in a note dated Thursday. The Swiss elevator maker has gained nearly 80% since October 2023, outperforming the broader European industrials sector by approximately 40 percentage points in euro terms. ...
By Melanie Burton and Clara Denina MELBOURNE/LONDON (Reuters) - An overwhelming majority of Rio Tinto (NYSE:RIO) shareholders sided with the board to vote against an activist fund proposal that the mining company should review its dual listing in Sydney and London. The mining giant said on Thursday that 19.35% of shareholders backed the motion put forward by London-based Palliser Capital. That wa ...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday downplayed CVS Health (NYSE:CVS)’s decision to drop the company’s obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell more than 10%. CVS said its pharmacy benefit management unit, which is the largest in the U.S., would drop Zepbound coverage from July 1, b ...